What is the Best Treatment for a Cancer Patient with Thrombosis?
Author(s) -
Miguel Barbosa
Publication year - 2014
Publication title -
clinical medicine insights oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.601
H-Index - 26
ISSN - 1179-5549
DOI - 10.4137/cmo.s13386
Subject(s) - medicine , venous thromboembolism , intensive care medicine , cancer , vitamin k , thrombosis , venous thrombosis , scientific evidence , cancer treatment , vitamin k antagonist , surgery , warfarin , philosophy , epistemology , atrial fibrillation
The relationship between venous thromboembolism and cancer has been known for many years, and there is solid scientific evidence addressing the adequate treatment of this condition in oncology patients. However, established prescribing habits, individual patient challenges, and uncertainty concerning treatment justifies poor adherence to published guidelines. This paper reviews venous thromboembolism treatment while focusing on vitamin K antagonists, low-molecular-weight heparins, and novel oral anticoagulants, namely in terms of their efficacy and limitations.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom